Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02113813
Title A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Site US10010 Washington District of Columbia 20007-2113 United States Details
Site US10006 Baltimore Maryland 21231 United States Details
Site US10012 Boston Massachusetts 02114 United States Details
Site US10001 Boston Massachusetts 02215 United States Details
Site US10011 Boston Massachusetts 02215 United States Details
Site US10008 New York New York 10065 United States Details
Site US10004 Chapel Hill North Carolina 27599 United States Details
Site US10005 Cleveland Ohio 44106 United States Details
Site US10009 Philadelphia Pennsylvania 19104 United States Details
Site US10002 Nashville Tennessee 37232 United States Details
Site US10003 Fairfax Virginia 22031 United States Details
Site US10007 Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field